Germany Nootropics Market Size & Outlook, 2021-2030
Germany nootropics market, 2018-2030 (US$M)
Related Markets
Germany nootropics market highlights
- The Germany nootropics market generated a revenue of USD 147.7 million in 2021 and is expected to reach USD 434.5 million by 2030.
- The Germany market is expected to grow at a CAGR of 12.7% from 2022 to 2030.
- In terms of segment, capsules/tablets was the largest revenue generating form in 2021.
- Drinks is the most lucrative form segment registering the fastest growth during the forecast period.
Nootropics market data book summary
| Market revenue in 2021 | USD 147.7 million |
| Market revenue in 2030 | USD 434.5 million |
| Growth rate | 12.7% (CAGR from 2021 to 2030) |
| Largest segment | Capsules/tablets |
| Fastest growing segment | Drinks |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capsules/Tablets, Powder, Drinks |
| Key market players worldwide | Reckitt Benckiser Group PLC, Mental Mojo, Noocube, Mind Lab, truBrain, Nooflux, Zhou Nutrition, Kimera Koffee |
Other key industry trends
- In terms of revenue, Germany accounted for 4.4% of the global nootropics market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany nootropics market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 359.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nootropics Market Scope
Nootropics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany nootropics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nootropics market will help companies and investors design strategic landscapes.
Capsules/tablets was the largest segment with a revenue share of 52.61% in 2021. Horizon Databook has segmented the Germany nootropics market based on capsules/tablets, powder, drinks covering the revenue growth of each sub-segment from 2018 to 2030.
The government of Germany has laid down various rules and regulations about the import of nootropics in the country. However, most of the approved products are easily imported into the country. Food & drug policies in the country are administered by the Federal Institute for Drugs and Medical Devices or BfArM, a federal authority within the German Federal Ministry of Health.
Various countries across the globe consume nootropics for their recreational value. However, BfArM tends to approve drugs based on their medical value as opposed to their recreational value.
Although the BfArM does not regulate Racetams other than Piracetam, there may be issues importing them into Germany as they are closely related to Piracetam, which is prescription only.
Reasons to subscribe to Germany nootropics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany nootropics market databook
-
Our clientele includes a mix of nootropics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany nootropics market , including forecasts for subscribers. This country databook contains high-level insights into Germany nootropics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Germany nootropics market size, by form, 2018-2030 (US$M)
Germany Nootropics Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
